Potential role of broad-spectrum azoles as therapy for Malasezzia bloodstream infection.
Med Mycol Case Rep
; 41: 1-3, 2023 Sep.
Article
in En
| MEDLINE
| ID: mdl-37251705
ABSTRACT
Amphotericin B is the currently recommended therapy for Malassezia invasive infection (MII), but this drug requires intravenous administration and is associated with significant toxicity. The role of broad-spectrum azoles in managing MII is not clear. We describe two cases of MII due to M. pachydermatis and M. furfur that were successfully treated with posaconazole and reviewed the literature to assess the position of posaconazole in treating MII.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Med Mycol Case Rep
Year:
2023
Document type:
Article
Affiliation country: